Sam Stone focuses his practice on creating and implementing strategies to develop and enforce intellectual property portfolios. His patent counseling and portfolio development practice includes both domestic and international patents and opinion work on the topics of patentability, clearance, validity, and infringement. Sam’s patents have survived dozens of PTAB invalidity challenges, and have been licensed by some of the largest software and technology companies in the world. Sam also assists clients with IP due diligence in investment transactions, mergers and acquisitions, and initial public offerings (IPOs).
Sam counsels software and electronics companies operating in many industries, including autonomous vehicles and industrial automation, automated machine learning (AutoML), cybersecurity, biosensors, and high-performance computing. In addition, Sam advises technology and life science companies on strategies for protecting their investments in data science, artificial intelligence (AI), and machine learning (ML) in domains such as drug discovery, medical devices, medical imaging, agricultural technology, biomanufacturing, biological systems modeling, and ‘omics’ technologies.
